IMMUNOVIA AB [CBOE] overview

The board member Philipp von Hugo resigns from Immunovia's board at his own request PR Newswire LUND, Sweden, May 6, 2023 LUND, Sweden , May 6, 2023 /PRNewswire/ -- Philipp von Hugo , member of the board of directors of Immunovia AB (publ) ("Immunovia" or the "Company"), has at his own request notified his resignation from the Board of Directors of the Company and therefore declines re-election at annual general meeting on 26 May 2023 . Philipp von Hugo , who has served as board member of...

Today, Immunovia, Inc., the American subsidiary of Immunovia AB (Nasdaq Stockholm: IMMNOV), announced that it has received final approval to begin patient testing for the IMMray ® PanCan-d test – the first blood test on the market dedicated to the early detection of pancreatic cancer. This approval was received from the Massachusetts Department of Public Health on August 3, 2021. Immunovia, Inc. received its CLIA Certificate of Registration on June 21, 2021 (CLIA Number: 22D2227265). “We...

CORRECTED VERSION: Nomination Committee appointed for the 2021 Annual General Meeting of Immunovia AB (Publ) PR Newswire LUND, Sweden, Nov. 11, 2020 Correction: The Nomination Committee's proposal will be presented in the notice convening the Annual General Meeting 2021, not 2020. According to the instructions for the Nomination Committee of Immunovia AB (Publ) that were adopted at the Annual General Meeting on May 7, 2020 , the Nomination Committee shall consist of four members. LUND, Sweden ,...